Gore touts reduced portal hypertension, complications in Viatorr Tips trial

W.L. Gore & Associates today released preliminary data from a trial of its Viatorr Tips endoprosthesis with controlled expansion, touting reduced portal hypertension treatment complications when compared to the company’s legacy Tips device and bare metal stents. Data from the study was presented at The International Liver Congress 2017 in Amsterdam, the Flagstaff, Ariz.-based company said. Preliminary data from the trial, which has 21 patients currently and is still enrolling, also indicated a reduction in hospital admissions from cirrhosis-related complications, including refractory ascites and sepsis, when the Viatorr Tips with CE was compared to bare metal stents. The Viatorr Tips endoprosthesis is a transjugular intrahepatic portosystemic shunt designed to create a new connection and reroute blood flow to reduce differences in pressure in the vein that connects digestive organs to the liver, and keep that new connection open. Researchers at Germany’s University of Bonn compared data from the 21 enrolled patients and retrospective data from 48 patients with the Gore Viatorr Tips endoprosthesis and 36 patients with a bare metal stent. At 3 months, the group with the Viatorr Tips with CE showed higher blood flow velocity and lowered MELD-Na scores, while both Viatorr groups showed reduced early splanchnic vein thrombosis compared to the bare metal stent group. Both Viatorr groups also reported fewer readmissions from sepsis, Gore said. Patients with the Viato...
Source: Mass Device - Category: Medical Devices Authors: Tags: Blood Management Clinical Trials Stent Grafts Stents Vascular W.L. Gore & Associates Source Type: news